Acadia Healthcare (NASDAQ:ACHC) Stock Price Expected to Rise, Barclays Analyst Says

Acadia Healthcare (NASDAQ:ACHC) had its price objective increased by Barclays from $14.00 to $20.00 in a research report issued on Tuesday,Benzinga reports. The firm currently has an “equal weight” rating on the stock. Barclays‘s price target would suggest a potential downside of 16.91% from the company’s current price.

A number of other analysts have also recently commented on ACHC. TD Cowen upped their target price on shares of Acadia Healthcare from $22.00 to $24.00 and gave the company a “buy” rating in a report on Thursday, February 26th. UBS Group boosted their price objective on shares of Acadia Healthcare from $24.00 to $27.00 and gave the company a “buy” rating in a research report on Thursday, February 26th. Cantor Fitzgerald set a $17.00 target price on Acadia Healthcare in a report on Wednesday, December 3rd. Deutsche Bank Aktiengesellschaft cut their price target on Acadia Healthcare from $33.00 to $20.00 and set a “buy” rating for the company in a report on Wednesday, December 3rd. Finally, Bank of America downgraded Acadia Healthcare from a “neutral” rating to an “underperform” rating and decreased their price objective for the stock from $21.50 to $13.00 in a research note on Wednesday, December 3rd. Seven equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $21.15.

Acadia Healthcare Stock Performance

Shares of ACHC opened at $24.07 on Tuesday. Acadia Healthcare has a one year low of $11.43 and a one year high of $31.43. The business has a fifty day moving average of $15.37 and a 200 day moving average of $18.62. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.55 and a quick ratio of 1.44. The firm has a market capitalization of $2.22 billion, a P/E ratio of -1.97, a PEG ratio of 7.77 and a beta of 0.74.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Wednesday, February 25th. The company reported $0.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.03 by $0.04. Acadia Healthcare had a positive return on equity of 6.53% and a negative net margin of 33.29%.The business had revenue of $821.46 million for the quarter, compared to analysts’ expectations of $800.10 million. During the same period last year, the firm posted $0.64 earnings per share. The business’s revenue for the quarter was up 6.1% on a year-over-year basis. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. As a group, sell-side analysts anticipate that Acadia Healthcare will post 3.38 EPS for the current year.

Institutional Trading of Acadia Healthcare

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. EverSource Wealth Advisors LLC boosted its stake in Acadia Healthcare by 54.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after purchasing an additional 497 shares during the period. Federated Hermes Inc. lifted its holdings in shares of Acadia Healthcare by 1.5% in the fourth quarter. Federated Hermes Inc. now owns 43,913 shares of the company’s stock worth $623,000 after buying an additional 668 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its position in shares of Acadia Healthcare by 0.9% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 74,907 shares of the company’s stock worth $1,063,000 after acquiring an additional 696 shares during the last quarter. Public Employees Retirement System of Ohio grew its stake in Acadia Healthcare by 2.8% during the third quarter. Public Employees Retirement System of Ohio now owns 31,335 shares of the company’s stock valued at $776,000 after acquiring an additional 867 shares in the last quarter. Finally, Treasurer of the State of North Carolina increased its holdings in Acadia Healthcare by 2.1% in the 2nd quarter. Treasurer of the State of North Carolina now owns 42,502 shares of the company’s stock valued at $964,000 after acquiring an additional 867 shares during the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.